Related Experiment Video
Updated: Jul 11, 2026

08:18
Preparation of Naringenin Solution for In Vivo Application
Published on: August 10, 2021
Pregnane glycosides from Solanum nigrum.
Xin-Lan Zhou1, Xiang-Jing He, Guang-Xiong Zhou
1Department of Natural Products Chemistry, Shenyang Pharmaceutical University, Shenyang, China.
Journal of Asian Natural Products Research
|September 22, 2007
Summary
Two novel pregnane saponins, solanigroside A and B, were identified in Solanum nigrum. These compounds, along with two known ones, were isolated and structurally characterized from the plant
Area of Science:
- Natural Product Chemistry
- Phytochemistry
- Organic Chemistry
Background:
- Solanum nigrum L. (black nightshade) is a widely distributed plant with a history of traditional medicinal use.
- Pregnane glycosides are a class of bioactive compounds found in various plant species, including Solanum species.
- Previous phytochemical investigations of Solanum species have revealed a diverse range of steroidal glycosides.
Purpose of the Study:
- To isolate and characterize novel pregnane saponins from Solanum nigrum L.
- To elucidate the chemical structures of the isolated compounds using spectroscopic methods.
- To contribute to the understanding of the phytochemical profile of Solanum nigrum.
Main Methods:
- Extraction of dried Solanum nigrum herb using 60% ethanol.
- Isolation of compounds using chromatographic techniques.
- Structural elucidation through extensive spectroscopic analysis (NMR, MS) and comparison with literature data.
Main Results:
- Isolation of two new pregnane saponins, designated solanigroside A (1) and solanigroside B (2).
- Characterization of solanigroside A and B with complex glycosidic linkages to a pregnane steroid core.
- Identification of two known compounds (3 and 4) alongside the new saponins.
Conclusions:
- The study successfully identified and characterized two new pregnane saponins from Solanum nigrum.
- The findings expand the knowledge of the chemical constituents of Solanum nigrum, particularly its steroidal glycosides.
- The isolated compounds, solanigroside A and B, represent novel additions to the family of pregnane saponins.
Related Concept Videos
Oral Hypoglycemic Agents: Glinides
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively manages...
Gonadal and Placental Hormones
The gonads, namely the testes in males and the ovaries in females, are pivotal in producing gonadal hormones that orchestrate the intricate processes of sexual development and reproduction.
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...
Glucagon-like Receptor Agonists
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Oral Hypoglycemic Agents: Sulfonylureas
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide (Glucotrol),...
Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
